openPR Logo
Press release

Global Pancreatic Cancer Drugs Market Growth, Size, Share, Industry Report and Forecast 2020-2026

02-18-2021 11:41 AM CET | Health & Medicine

Press release from: Orion Market Research

Global Pancreatic Cancer Drugs Market Growth, Size, Share,

The global pancreatic cancer drugs market has significant opportunity owing to the emerging drugs in the pipeline for the treatment of pancreatic cancer. Several immunotherapies and targeted therapies are under the pipeline.

Immunotherapies are mostly in trial stages and less is available on the market for the treatment of pancreatic cancer. Several immunotherapy options are available on the market for the treatment of other cancer types, including breast cancer and some are under trials for pancreatic cancer. In 2017, the US FDA approved pembrolizumab (Keytruda), an immunotherapy to treat pancreatic cancer patients with certain genetic mutations and is manufactured by Merck.

To Request a Sample of our Report on Global Pancreatic Cancer Drugs Market: https://www.omrglobal.com/request-sample/pancreatic-cancer-drugs-market

The drug may be an alternative for a small percentage of people suffering from unresectable pancreatic cancer. It works by blocking the ability of cancer cells’ to avoid an immune attack. Cancers with high microsatellite instability (MSI) have been demonstrated to be mainly prone to treatment with Keytruda. High MSI can be found in pancreatic cancers, however, it is not common. Targeted therapies that are available for the treatment of pancreatic cancers include Erlotinib and Larotrectinib (Vitrakvi). The US FDA approved Erlotinib for patients living with advanced pancreatic cancer along with the chemotherapy drug Gemzar (gemcitabine).

Erlotinib is used to block the epidermal growth factor receptor (EGFR) effect. EGFR is a protein that can become abnormal and support the growth and spread of cancer. One of the major instance for targeted therapy under trial is Lupin’s MEK inhibitor compound (LNP3794). In September 2019, Boehringer Ingelheim and Lupin Ltd. declared a licensing, development, and commercialization agreement for Lupin’s MEK inhibitor compound (LNP3794) as an effective targeted therapy for patients suffering from difficult-to-treat cancers. This collaboration intends for the development of Lupin’s lead MEK inhibitor compound along with one of innovative KRAS inhibitors of Boehringer Ingelheim for patients suffering from lung and gastrointestinal cancers harboring a comprehensive spectrum of oncogenic KRAS mutations.

KRAS mutations occur in one in seven of entire human metastatic cancers which makes it the most often mutated cancer-causing gene, with mutation rates of over 90% in pancreatic cancers, over 40% in colorectal cancers and over 30% in lung adenocarcinomas. Lupin’s MEK Inhibitor program has cleared early clinical stages. The emerging trials on such kinds of novel drugs will likely offer an opportunity for more reliable, accurate, and potential treatment for pancreatic cancer. This, in turn, is expected to accelerate the growth of the global pancreatic cancer drugs market.

(Get 15% Discount on Buying this Report)
A full Report of Global Pancreatic Cancer Drugs Market is Available at: https://www.omrglobal.com/industry-reports/pancreatic-cancer-drugs-market

Global Pancreatic Cancer Drugs Market- Segmentation

By Cancer Type

• Exocrine
• Endocrine

By Treatment Type

• Chemotherapy Drugs
• Targeted Therapy Drugs
• Immunotherapy Drugs

Global Pancreatic Cancer Drugs Market– Segment by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• The Middle East and Africa

Company Profiles
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Co.
• Cipla Ltd.
• Clovis Oncology, Inc.
• Eli Lilly and Co.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Kura Oncology, Inc.
• Lupin Ltd.
• Merck & Co., Inc.
• Novartis International AG
• Pfizer Inc.
• PharmaCyte Biotech, Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pancreatic-cancer-drugs-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pancreatic Cancer Drugs Market Growth, Size, Share, Industry Report and Forecast 2020-2026 here

News-ID: 2244655 • Views:

More Releases from Orion Market Research

Toothpaste Market Increasing Demand, Growth Analysis and Future Outlook by 2031/ Colgate-Palmolive Co., GlaxoSmithKline plc, Johnson & Johnson
Toothpaste Market Increasing Demand, Growth Analysis and Future Outlook by 2031/ …
The global toothpaste market is anticipated to grow with a considerable CAGR during the forecast period. The daily usage of toothpaste aids in maintain cleanliness and freshens the mouth. Numerous advantages of toothpaste such as the rebuilding of enamel strength, protection against acids, protection against cavities, keeps teeth and gums healthy are the major factors driving the adoption of toothpaste. Additionally, the emphasis on maintaining personal appearance is increasing significantly
Synthetic Fibers Market Will Exhibit an Impressive Expansion by 2024-2031 | Asahi Kasei Corp., Bombay Dyeing & Manufacturing Co Ltd., BASF SE
Synthetic Fibers Market Will Exhibit an Impressive Expansion by 2024-2031 | Asah …
Synthetic Fibers Market is estimated to have significant CAGR of during the forecast period. Synthetic fiber is engineered and developed as an alternative to natural fibers. Owing to its various properties such as improve tance and thermal stability, high toughness and rigidity, outstanding resistance to weather, aging, and yellowing, and high gloss. synthetic caters to its use in major applications such as automotive, textiles, home furnishing, filtration, and many more
Sports Nutrition Market Size Report Predicts Healthy Growth with Demand & Forecasts by 2031 / Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc.
Sports Nutrition Market Size Report Predicts Healthy Growth with Demand & Foreca …
The global sports nutrition market is projected to grow at a CAGR of 8.8% during the forecast period. The major aspect that drives the growth of the market includes the rising demand for various protein powders, bars, and supplements among athletes and sportspersons for various purposes such as energy supplements, recovery supplements, and performance-enhancing supplements. Another major aspect that drives the growth of the market is the increasing disposable incomes,
Portable Sewing Machine Market Update Report 2024| Industry Trends, Demand, Leading Companies and Segmentation till 2031/ BERNINA International AG., Elna International Corp., Embroiderysewingmachines
Portable Sewing Machine Market Update Report 2024| Industry Trends, Demand, Lead …
The global portable sewing machine market is anticipated to grow at a considerable CAGR during the forecast period. Portable sewing machine manufacturers in the market have come up with sewing machines in a lightweight and compact design with additional features such as automatic buttonholer, power switch, and others that is driving the demand of the market. Changing customer preferences is fuelling the consumer demand for smart portable sewing machines that

All 5 Releases


More Releases for Drugs

Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information: https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$
Prospect of Global Excipients Market Research Report 2017 with Application inclu …
ResearchMoz added Latest Research Report titled " Global Excipients Market Research Report 2017 " to it's Large Report database. In this report, the global Excipients market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD),
Drugs research: Misuse by shareholders of the drugs industry
A new textbook illustrates the complex and multi-faceted dimensions of evidence building in European drugs research. On one level, the authors have identified practical and philosophical challenges regarding knowledge production including, for example, measurements of the drugs problem; researching the online world; and interpreting on-site drug tests. On another level, the authors have highlighted challenges regarding knowledge production such as the misuse of evidence by knowledge brokers and policymakers.